Examining the Quality Attributes of UNITED THERAPEUTICS CORP (NASDAQ:UTHR).

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if UNITED THERAPEUTICS CORP (NASDAQ:UTHR) is suited for quality investing. Investors should of course do their own research, but we spotted UNITED THERAPEUTICS CORP showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

What matters for quality investors.

• UTHR has demonstrated significant revenue growth over the past 5 years, with a 14.71% increase. This underscores the company's ability to adapt to market dynamics and capitalize on growth opportunities.
• UTHR exhibits a strong ROIC excluding cash and goodwill, indicating efficient capital utilization and profitable operations. The 34.55% reflects the company's ability to generate returns on invested capital and underscores its commitment to delivering value to shareholders.
• With a favorable Debt/Free Cash Flow Ratio of 0.28, UTHR showcases its sound financial discipline and cash flow management. This ratio indicates the company's ability to service its debt obligations while maintaining sufficient free cash flow for future investments or operational needs.
• UTHR demonstrates consistent Profit Quality over the past 5 years, with a strong 98.64%. This indicates the company's ability to generate sustainable and reliable profits, showcasing its long-term profitability and financial stability.
• UTHR has experienced impressive EBIT growth over the past 5 years, with 17.97% increase. This reflects the company's effective operational performance and highlights its potential for long-term financial success.
• UTHR demonstrates a remarkable trend where its EBIT 5-year growth exceeds its Revenue 5-year growth. This indicates the company's ability to enhance its profitability through improved cost control and operational efficiency.

Fundamental Analysis Observations

ChartMill assigns a Fundamental Rating to every stock. This score ranges from 0 to 10 and is updated daily. The score is determined by evaluating multiple fundamental indicators and properties.

Taking everything into account, UTHR scores 7 out of 10 in our fundamental rating. UTHR was compared to 563 industry peers in the Biotechnology industry. UTHR has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. UTHR scores decently on growth, while it is valued quite cheap. This could make an interesting combination. These ratings could make UTHR a good candidate for value and quality investing.

For an up to date full fundamental analysis you can check the fundamental report of UTHR

Our Caviar Cruise screen will find you more ideas suited for quality investing.

Disclaimer

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.